Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...

The clinical evidence gathered in this study demonstrates that dietary changes can significantly enhance the effectiveness of conventional treatments for hypertension. Research shows that ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...

Hypertension in pregnancy increases the likelihood of postpartum hypertension. Know the risk factors to start managing ...

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...